Branded generics are sold under a brand name without a patent. They can be developed by a generic drug firm or the original manufacturer and marketed after the original drug’s patent expires. An Abbreviated New Drug Application (ANDA) is submitted for regulatory approval, and it must be therapeutically equivalent to the original drug.ย
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ ๐๐จ๐ฉ๐ฒ @ https://www.theinsightpartners.com/sample/TIPRE00005554
The List of Companiesย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย
Valeant Pharmaceuticals International, Inc.
- Hetero
- Aspen Holdings
- Sandoz International GMBH
- Par Pharmaceuticals, INC
- Reddy’s Laboratories
- AstraZeneca PLC
- Sanofi
- Lupin
- Bausch Health Companies Inc.
- GlaxoSmithKline plc.
- Teva Pharmaceutical Industries Ltd
- Mylan N.V
By Therapeutic Application
- Oncology
- Cardiovascular Diseases
- Diabetes
- Neurology
- Gastrointestinal Diseases
- Dermatology Diseases
- Analgesics & Anti-Inflammatory
By Drug Class
- Alkylating Agents
- Antimetabolites
- Hormones
- Antihypertensive
- Lipid-Lowering Drugs
- Antidepressants
- Antipsychotics
- Antiepileptic
By Formulation Type
- Oral
- Parenteral
- Topical
By Distribution Channel
- Hospitals
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.
Contact US
Contact Person : Ankit Mathur
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com
